Myoclonic status in severe tetanus patients on diazepam
Odusote, K.; Apantaku, J.B.; Femi-Pearse, D.
East African Medical Journal 52(10): 571-572
1975
ISSN/ISBN: 0012-835X PMID: 1204539 Document Number: 88296
Document emailed within 1 workday
Related Documents
Moreno-Izco, F.; Ruibal, M. 2006: Myoclonic seizures induced by tramadol in patients with juvenile myoclonic epilepsy Revista de Neurologia 43(4): 255Bojarski, Z.; Szczotka, W.; Jahns-Bojarska, K. 1975: Combined treatment of tetanus with diazepam and inderal Wiadomosci Lekarskie 28(1): 19-22
Sehgal, H.; Wadhwa, S.; Lal, C. 1978: Evaluation of diazepam as an anticonvulsant in the treatment of tetanus neonatorum Indian Pediatrics 15(2): 161-165
Billimoria, R.B.; Chhabra, R.H.; Satoskar, R.S. 1981: Evaluation of diazepam alone and in combination with chlorpromazine or propranolol in the therapy of tetanus Journal of Postgraduate Medicine 27(2): 80-85
Soetomenggolo, T.S.; Purboyo, R.H.; Hendarto, S.K.; Ismael, S. 1981: Neonatal tetanus treated with diazepam as single antispasmodic agent Paediatrica Indonesiana 21(5-6): 101-106
Haider, W.; Tschakaloff, C. 1970: Temporary mental after-effects in long-term treatment of tetanus with diazepam (Valium) Der Anaesthesist 19(5): 165-168
Kotwica, S.; Dzialek, E.; Split, W.; Rydzewski, W. 1973: Myoclonic petit mal status Neurologia i Neurochirurgia Polska 7(1): 93-96
Brodmerkel, C.; Wadman, E.; Langley, R.G.; Papp, K.A.A.; Bourcier, M.; Poulin, Y.; Ho, V.; Guenther, L.; Kunynetz, R.; Nigen, S.; Vender, R.; Wasel, N.; Hsu, M.-C.; Szapary, P. 2013: Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use Journal of Drugs in Dermatology: Jdd 12(10): 1122-1129
Fernández-Jaén, A.; León, M.C.; Martínez-Granero, M.A.; Martínez-Bermejo, A.; López-Martín, V.; Pascual-Castroviejo, I. 1998: Diagnosis in severe myoclonic epilepsy in childhood: study of 13 cases Revista de Neurologia 26(153): 759-762
2005: Stiripentol: new preparation. Severe myoclonic epilepsy of infancy: promising Prescrire International 14(76): 57-59
Dalla Bernardina, B.; Fontana, E.; Darra, F. 2005: Myoclonic status in nonprogressive encephalopathies Advances in Neurology 95: 59-70
Tanabe, T.; Awaya, Y.; Matsuishi, T.; Nagai, T.; Yamamoto, K.; Kurihara, M.; Iyoda, K.; Maekawa, K. 2004: Survey of vaccination and viral infections for children with severe myoclonic epilepsy in infancy No to Hattatsu 36(4): 318-323
Young, G.B.; Gilbert, J.J.; Zochodne, D.W. 1990: The significance of myoclonic status epilepticus in postanoxic coma Neurology 40(12): 1843-1848
Nieto Barrera, M.; Candau Fernandez Mensaque, R.; Nieto Jiménez, M. 2003: Severe myoclonic epilepsy in infancy (Dravet's syndrome). its nosological characteristics and therapeutic aspects Revista de Neurologia 37(1): 64-68
Ohfu, M. 1995: High amplitude somatosensory evoked potentials in a case of severe myoclonic epilepsy in infancy (SMEI) No to Hattatsu 27(1): 62-64
Mazza, S.; Ferro, F.M.; Bergonzi, P. 1976: Generalized status epilepticus of confusional manifestation in a patient with Ramsay Hunt myoclonic cerebellar dyssynergia Rivista di Neurologia 46(6): 508-514
Chatoorgoon, A.; Sivapragasam, S. 1980: Salt wasting in severe tetanus West Indian Medical Journal 29(2): 147-150
Bharani, A.K.; Mehta, R.S.; Jain, A.C.; Bhargava, S. 1984: Common peroneal neuropathy in severe tetanus Journal of the Association of Physicians of India 32(12): 1075-1076
Lukić, I.; Marinković, E.; Filipović, A.; Krnjaja, O.; Kosanović, D.; Inić-Kanada, A.; Stojanović, M. 2015: Key protection factors against tetanus: Anti-tetanus toxin antibody affinity and its ability to prevent tetanus toxin - ganglioside interaction Toxicon: Official Journal of the International Society on Toxinology 103: 135-144
Feischl, P.; Hiotakis, K. 1972: Long-term parenteral feeding in severe tetanus Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Beiheft 12: 197-203